Dimethylamine

Dimethylamine

SCHEMBL3834248

CCOC(=O)C(C)c1cccc(C(=O)c2ccccc2)c1.CNC

nearest known ligand 0.72

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 7/20 0.72
PTGS1 P23219 6/20 0.72
MAPT P10636 5/20 0.62
SMN1; SMN2 Q16637 3/20 0.62
ALDH1A1 P00352 3/20 0.62
LMNA P02545 3/20 0.62
CXCR1 P25024 2/20 0.62
CXCR2 P25025 2/20 0.62
CYP3A4 P08684 2/20 0.62
RECQL P46063 1/20 0.62
KDM4E B2RXH2 1/20 0.62
HPGD P15428 1/20 0.62
MAPK1 P28482 1/20 0.62
PMP22 Q01453 1/20 0.62
SLC22A6 Q4U2R8 1/20 0.62
HSD17B10 Q99714 1/20 0.62
CXCL8 P10145 1/20 0.62
THPO P40225 1/20 0.62
HIF1A Q16665 1/20 0.62
HTT P42858 3/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30436399 0.96 PTGS2 (0.74) PTGS2PTGS1MAPTSMN1; SMN2ALDH1A1
SCHEMBL9555892 0.96 PTGS2 (0.74) PTGS2PTGS1MAPTSMN1; SMN2ALDH1A1
SCHEMBL27296808 0.85 PTGS2 (0.59) PTGS2PTGS1MAPTSMN1; SMN2ALDH1A1
SCHEMBL21908445 0.85 PTGS2 (0.70) PTGS2PTGS1MAPTSMN1; SMN2ALDH1A1
SCHEMBL10595130 0.85 PTGS2 (0.62) PTGS2PTGS1MAPTSMN1; SMN2ALDH1A1
SCHEMBL9086931 0.84 PTGS1 (1.00) PTGS2PTGS1MAPTSMN1; SMN2ALDH1A1
SCHEMBL12935378 0.84 PTGS1 (1.00) PTGS2PTGS1MAPTSMN1; SMN2ALDH1A1
SCHEMBL577323 0.84 PTGS1 (1.00) PTGS2PTGS1MAPTSMN1; SMN2ALDH1A1
SCHEMBL8754918 0.84 PTGS1 (1.00) PTGS2PTGS1MAPTSMN1; SMN2ALDH1A1
SCHEMBL4480248 0.84 PTGS1 (0.65) PTGS2PTGS1MAPTSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090238763-A1 HIGH PENETRATION COMPOSITIONS AND USES THEREOF TECHFIELDS PHARMA CO., LTD. (CN) 2009-09-24 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090238763-A1 HIGH PENETRATION COMPOSITIONS AND USES THEREOF HPGDS, PTGIS, PTGES PTGS2 7/4885PTGS1 4/4885MAPT 3194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.